Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway

Hepatic steatosis, an indicator of atherosclerosis (AS), is always accompanied by inflammatory responses and disturbances in lipid metabolism. The present study investigated the protective effect of urantide, a urotensin II (UII) receptor antagonist, on the liver of rats with AS with hepatic steatos...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Haipeng, Lin, Yingxue, Xie, Lide, Zhao, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905324/
https://www.ncbi.nlm.nih.gov/pubmed/33604686
http://dx.doi.org/10.3892/mmr.2021.11923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905324/
https://www.ncbi.nlm.nih.gov/pubmed/33604686
http://dx.doi.org/10.3892/mmr.2021.11923

Ejemplares similares